Objective To evaluate the association between recently raised anticholinergic burden and risk of acute cardiovascular events in older adults. Design Case-case-time-control study (ie …
E Perdixi, M Cotta Ramusino, A Costa, S Bernini… - European Journal of …, 2024 - Springer
Polypharmacy (PP) use is very common in older people and may lead to drug-drug interactions (DDIs) and anticholinergic burden (ACB) that may affect cognitive function. We …
J Riis, K Kragholm, MM Søndergaard… - Age and …, 2024 - academic.oup.com
Background Recent studies have shown that anticholinergic medications are associated with cardiovascular disease. Little is known about how discontinuation of anticholinergic …
Polypharmacy (use of≥ 5 concurrent medications) is highly prevalent among older adults to manage chronic diseases and is linked to adverse geriatric outcomes, including physical …
A Miranda - Frontiers in Pain Research, 2024 - frontiersin.org
In 1959, Dr. John Apley first published the book, The Child with Abdominal Pains, and described what he called “little bellyachers”. We now know these conditions as functional …
Background A growing body of research supports the negative impact of anticholinergic drug burden on physical frailty. However, prior research has been limited to homogeneous …
Confidential: For Review Only Page 1 Confidential: For Review Only Association between recently elevated anticholinergic burden and risk of acute cardiovascular events: A nationwide …
HU Michael, MJ Brouillette, R Tamblyn… - JAIDS Journal of …, 2022 - journals.lww.com
Objective: To estimate the extent to which comorbidity, polypharmacy, and anticholinergic/ sedative burden interrelate to influence cognitive ability, perceived cognitive deficits and …
Observational studies have shown an association between the use of anticholinergic drugs and various negative health outcomes. However, when studying cognitive outcomes, there …